T‐17, a novel cyclin‐dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis
T‐17, a novel cyclin‐dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis
复制标题
T-17 是一种新型细胞周期蛋白依赖性激酶/组蛋白脱乙酰酶双重抑制剂,通过细胞周期停滞和细胞凋亡诱导癌细胞死亡
DOI:
10.1002/ddr.21977
复制
发表时间:
2022-07
影响因子:
3.8
通讯作者:
Zongjie Gan
中科院分区:
文献类型:
--
作者:
Lin Zhang;Rui Long;Xiaoli Li;Junhao Jiang;Huali Chen;Binghua Tian;Binyu Long;Yu Yu;Zongjie Gan
Combination of cyclin-dependent kinases (CDKs) and histone deacetylases (HDACs) inhibitors may have statistical synergy in suppressing cancer cell proliferation. Herein, a novel CDKs/HDACs dual inhibitor T-17 was rationally designed, synthesized, and evaluated. Our results demonstrated that T-17 concurrently exhibited potent and balanced inhibitory activity against CDKs (IC50 = 18.0 nM) and HDACs (IC50 = 6.6 nM) and also displayed good cell viability inhibitory effect on four cancer cell lines. Meanwhile, T-17 blocked the MDA-MB-231 and A549 cell cycle at G1 phase and S phase, respectively. In addition, T-17 induced MDA-MB-231 cells apoptosis and inhibited the HDACs and CDKs mediated signaling pathways. Finally, we also found that T-17 had good antitumor activity in vivo. In summary, these results indicated that T-17 would be a promising lead compound which deserves further research.
登录
查看更多内容
影响因子:
4.1
作者:
Wang Lijun;Zhang Shuhong;Yu Xuemin;Guo Chuanlong
通讯作者:
Guo Chuanlong
DOI:
10.1016/j.biopha.2016.10.057
发表时间:
2016-12
期刊:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
影响因子:
--
作者:
Lubna Wasim;Madhu Chopra
通讯作者:
Lubna Wasim;Madhu Chopra
影响因子:
2.7
作者:
Yu Yu-Yu;Dongzhi Ran;junhao jiang;Tao Pan;Yanrong Dan;Q. Tang;Wei Li;Lin Zhang;Linling Gan;Zongjie Gan
通讯作者:
Yu Yu-Yu;Dongzhi Ran;junhao jiang;Tao Pan;Yanrong Dan;Q. Tang;Wei Li;Lin Zhang;Linling Gan;Zongjie Gan
影响因子:
7.3
作者:
Tang, Guozhi;Nikolovska-Coleska, Zaneta;Wang, Shaomeng
通讯作者:
Wang, Shaomeng
影响因子:
7.3
作者:
T. Liang;Yi Zhou;Reham M. Elhassan;Xuben Hou;Xinying Yang;H. Fang
通讯作者:
T. Liang;Yi Zhou;Reham M. Elhassan;Xuben Hou;Xinying Yang;H. Fang